Status:
RECRUITING
Optimization of DE-CTPA Images and Diagnostic Pathway: Using Low Concentration Iodine Contrast Material
Lead Sponsor:
Wuxi People's Hospital
Conditions:
Pulmonary Embolism
Eligibility:
All Genders
18-90 years
Brief Summary
The investigators aimed to compare the image quality and diagnostic performance of DECTPA using lower concentration iodine contrast materials and using normal concentration iodine contrast materials i...
Detailed Description
All patients met the inclusion and exclusion criteria will be given written informed consensus. The enrolled patients will randomly receive one of the three injection protocols: A: 30mL Iomeprol (Iome...
Eligibility Criteria
Inclusion
- Age greater than 18 years old
- Clinical suspicion of pulmonary embolism suggests CTPA examination (Wells score\>4 or D-2 polymer elevation)
- Patient's general physical condition tolerates CTPA examination
Exclusion
- Allergy to iodine contrast agents
- Hyperthyroidism
- Pregnancy
- Weight greater than 80kg
- Heart failure patients, NYHA heart function level III or IV
Key Trial Info
Start Date :
September 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2025
Estimated Enrollment :
2100 Patients enrolled
Trial Details
Trial ID
NCT06212882
Start Date
September 1 2023
End Date
June 1 2025
Last Update
January 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Wuxi People's Hospital
Wuxi, Jiangsu, China, 214043